Skip to main content
Journal cover image

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

Publication ,  Journal Article
Castellano, CA; Sun, T; Ravindranathan, D; Hwang, C; Balanchivadze, N; Singh, SRK; Griffiths, EA; Puzanov, I; Ruiz-Garcia, E; Vilar-Compte, D ...
Published in: Cancer
June 15, 2024

BACKGROUND: COVID-19 can have a particularly detrimental effect on patients with cancer, but no studies to date have examined if the presence, or site, of metastatic cancer is related to COVID-19 outcomes. METHODS: Using the COVID-19 and Cancer Consortium (CCC19) registry, the authors identified 10,065 patients with COVID-19 and cancer (2325 with and 7740 without metastasis at the time of COVID-19 diagnosis). The primary ordinal outcome was COVID-19 severity: not hospitalized, hospitalized but did not receive supplemental O2, hospitalized and received supplemental O2, admitted to an intensive care unit, received mechanical ventilation, or died from any cause. The authors used ordinal logistic regression models to compare COVID-19 severity by presence and specific site of metastatic cancer. They used logistic regression models to assess 30-day all-cause mortality. RESULTS: Compared to patients without metastasis, patients with metastases have increased hospitalization rates (59% vs. 49%) and higher 30 day mortality (18% vs. 9%). Patients with metastasis to bone, lung, liver, lymph nodes, and brain have significantly higher COVID-19 severity (adjusted odds ratios [ORs], 1.38, 1.59, 1.38, 1.00, and 2.21) compared to patients without metastases at those sites. Patients with metastasis to the lung have significantly higher odds of 30-day mortality (adjusted OR, 1.53; 95% confidence interval, 1.17-2.00) when adjusting for COVID-19 severity. CONCLUSIONS: Patients with metastatic cancer, especially with metastasis to the brain, are more likely to have severe outcomes after COVID-19 whereas patients with metastasis to the lung, compared to patients with cancer metastasis to other sites, have the highest 30-day mortality after COVID-19.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

June 15, 2024

Volume

130

Issue

12

Start / End Page

2191 / 2204

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • SARS-CoV-2
  • Retrospective Studies
  • Respiration, Artificial
  • Registries
  • Oncology & Carcinogenesis
  • Neoplasms
  • Neoplasm Metastasis
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Castellano, C. A., Sun, T., Ravindranathan, D., Hwang, C., Balanchivadze, N., Singh, S. R. K., … COVID‐19 and Cancer Consortium. (2024). The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer, 130(12), 2191–2204. https://doi.org/10.1002/cncr.35247
Castellano, Cecilia A., Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R. K. Singh, Elizabeth A. Griffiths, et al. “The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cancer 130, no. 12 (June 15, 2024): 2191–2204. https://doi.org/10.1002/cncr.35247.
Castellano CA, Sun T, Ravindranathan D, Hwang C, Balanchivadze N, Singh SRK, et al. The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer. 2024 Jun 15;130(12):2191–204.
Castellano, Cecilia A., et al. “The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Cancer, vol. 130, no. 12, June 2024, pp. 2191–204. Pubmed, doi:10.1002/cncr.35247.
Castellano CA, Sun T, Ravindranathan D, Hwang C, Balanchivadze N, Singh SRK, Griffiths EA, Puzanov I, Ruiz-Garcia E, Vilar-Compte D, Cárdenas-Delgado AI, McKay RR, Nonato TK, Ajmera A, Yu PP, Nadkarni R, O’Connor TE, Berg S, Ma K, Farmakiotis D, Vieira K, Arvanitis P, Saliby RM, Labaki C, El Zarif T, Wise-Draper TM, Zamulko O, Li N, Bodin BE, Accordino MK, Ingham M, Joshi M, Polimera HV, Fecher LA, Friese CR, Yoon JJ, Mavromatis BH, Brown JT, Russell K, Nanchal R, Singh H, Tachiki L, Moria FA, Nagaraj G, Cortez K, Abbasi SH, Wulff-Burchfield EM, Puc M, Weissmann LB, Bhatt PS, Mariano MG, Mishra S, Halabi S, Beeghly A, Warner JL, French B, Bilen MA, COVID‐19 and Cancer Consortium. The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer. 2024 Jun 15;130(12):2191–2204.
Journal cover image

Published In

Cancer

DOI

EISSN

1097-0142

Publication Date

June 15, 2024

Volume

130

Issue

12

Start / End Page

2191 / 2204

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • SARS-CoV-2
  • Retrospective Studies
  • Respiration, Artificial
  • Registries
  • Oncology & Carcinogenesis
  • Neoplasms
  • Neoplasm Metastasis
  • Middle Aged
  • Male